FDA Clears Dexcom G7 CGM System for Persons with T1D and T2D
The Dexcom G7 continuous glucose monitoring system provides an overall MARD of 8.2%, the highest of any FDA-cleared CGM, the company says.
Daily Dose: Statin Treatment, Duration Linked to Reduced Risk of Hemorrhagic Stroke
Your daily dose of clinical news you may have missed.
COVID-19 Vaccines Have Saved 3 Million Lives in the 2 Years Since the First EUA
The vaccination campaign in the US also has prevented more than 18 million hospitalizations and saved $1 trillion in medical costs, according to a modeling study.
Concomitant Gestational Diabetes and Hypertensive Disorder Increase Long-term Postpartum CVD Risk
Having both conditions while pregnant in the current study conferred more than double the risk of future CVD vs having either condition alone.
Empagliflozin Reduces HbA1c, FPG in Pediatric Population with Type 2 Diabetes
Empagliflozin is the first SGLT-2 inhibitor to demonstrate a statistically significant reduction in HbA1c in children and adolescents with type 2 diabetes.
9 Indicators of Personal Stress and How the 50 States Rank
From crime rates and credit scores to average health and hours worked in a week, find the 5 states that rank highest and the 5 lowest across 9 composite measures of stress.
Dementia: New Screening Tool to be Evaluated in Primary Care
The NIH has awarded $11 million for evaluation of a 5-minute, largely visual screening test for dementia intended for use in primary care practice.
Statin Treatment and Duration Associated with Reduced Risk of Hemorrhagic Stroke
Similar reduction in risk was reported for both lobar and nonlobar intracranial hemorrhage with longer statin treatment associated with greater protection, according to Danish investigators.
Daily Dose: Pediatric Obesity Treatment
FDA Grants Priority Review to Pfizer’s RSV Vaccine Candidate for Older Americans
The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for adults aged ≥60 years.
FDA Authorizes Bivalent COVID-19 Vaccines as Booster Dose in Children Aged 6 Months to 5 Years
The FDA amended Pfizer and Moderna EUAs for updated COVID-19 vaccines to include children as young as age 6 months as holidays and winter weather approach.
Respiratory Virus Season Update: By the Numbers
Bempedoic Acid Meets Primary Endpoint in Key Cardiovascular Outcomes Trial: CLEAR
Approved in 2020 as Nexletol, bempedoic acid as the first ATP citrate lyase inhibitor and oral non-statin therapy to meet the MACE-4 primary endpoint.
FDA Grants Priority Review to sNDA for OTC Intranasal Naloxone HCl
The Agency's priority review of the prescription-OTC switch underscores the urgent need for broader access to the opioid overdose reversal agent.
Drug Overdose Deaths Reach Record High among Pregnant, Postpartum Women in US
Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.
Butryate Supplementation May Support Pediatric Obesity Treatment
Findings from a new study suggest that supplementing standard care for obesity with butyrate helped reduce BMI, improve glucose metabolism, and reduce inflammation markers.
Daily Dose: Statin Prescribing in Primary Care
Influenza Update: Hospital Admissions Double During post-Thanksgiving Week
The inpatient flu census doubled after Thanksgiving travel and gatherings and ICU beds are full. More at-a-glance stats on Flu in the USA, here.
Daily Dose: Morning Exercise Reduces Risk for Cardiovascular Disease
Pfizer-BioNTech Seek EUA for Omicron Booster in Children Aged Under 5 Years
Pfizer and BioNTech submitted an application to the FDA for emergency use authorization of their omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.
